5.07
BATS BZX Real-Time Price
As of 3:42pm ET
 -0.38 / -6.97%
Today’s Change
2.88
Today|||52-Week Range
7.75
+2.22%
Year-to-Date
New Strong Sell Stocks for September 10th
Sep 10 / Zacks.com - Paid Partner Content
Crinetics Pharmaceuticals- Superior Molecules In Endocrinology
Sep 01 / Seeking Alpha - Paid Partner Content
Crinetics Pharma to advance ACTH antagonist candidate into the clinic
Sep 04 / Seeking Alpha - Paid Partner Content
Chiasma announces U.S. commercial launch and availability of MYCAPSSA
Aug 31 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close5.45
Today’s open5.46
Day’s range5.02 - 5.46
Volume15,965
Average volume (3 months)698,112
Market cap$313.9M
Data as of 3:42pm ET, 09/21/2020

Growth & Valuation

Earnings growth (last year)+17.12%
Earnings growth (this year)-56.79%
Earnings growth (next 5 years)+38.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.66

Competitors

 Today’s
change
Today’s
% change
UROVUrovant Sciences Ltd-0.72-7.18%
IPHAInnate Pharma SA0.000.00%
CNCEConcert Pharmaceutic...-0.42-3.94%
VYNEVyne Therapeutics In...-0.16-8.42%
Data as of 3:43pm ET, 09/21/2020

Financials

Next reporting dateNovember 5, 2020
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$0.00
Annual profit (last year)-$36.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Needham, Massachusetts

Forecasts